Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immunitybio Inc (IBRX)

Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immunitybio Inc 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 USA

www.immunitybio.com Employees: 680 P: 844-696-5235

Sector:

Medical

Description:

ImmunityBio Inc. is a late-clinical-stage immunotherapy company developing therapies which drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems. ImmunityBio Inc., formerly known as NantKwest Inc., is based in CULVER CITY, Calif.

Key Statistics

Overview:

Market Capitalization, $K 10,054,925
Enterprise Value, $K 9,911,495
Shares Outstanding, K 1,028,111
Float, K 313,779
% Float 30.52%
Short Interest, K 135,161
Short Float 13.72%
Days to Cover 1.69
Short Volume Ratio 0.58
% of Insider Shareholders 69.48%
% of Institutional Shareholders 8.58%

Financials:

Annual Sales, $ 14,750 K
Annual Net Income, $ -413,560 K
Last Quarter Sales, $ 32,060 K
Last Quarter Net Income, $ -67,250 K
EBIT, $ -260,750 K
EBITDA, $ -222,100 K

Growth:

1-Year Return 241.96%
3-Year Return 393.94%
5-Year Return -63.51%
5-Year Revenue Growth 36,775.00%
5-Year Earnings Growth -4.29%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 11/04/25
Next Earnings Date 05/11/26
Earnings Per Share ttm -0.47
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year 60.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IBRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -81.40%
Profit Margin % -2,803.80%
Debt/Equity 0.00
Price/Sales 88.76
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.53
Interest Coverage -1.68
60-Month Beta 0.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar